Correlation Between Kilitch Drugs and Par Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Par Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Par Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and Par Drugs And, you can compare the effects of market volatilities on Kilitch Drugs and Par Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Par Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Par Drugs.

Diversification Opportunities for Kilitch Drugs and Par Drugs

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kilitch and Par is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Par Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Par Drugs And and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Par Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Par Drugs And has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Par Drugs go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Par Drugs

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 0.75 times more return on investment than Par Drugs. However, Kilitch Drugs Limited is 1.34 times less risky than Par Drugs. It trades about 0.0 of its potential returns per unit of risk. Par Drugs And is currently generating about -0.75 per unit of risk. If you would invest  32,015  in Kilitch Drugs Limited on November 27, 2024 and sell it today you would lose (225.00) from holding Kilitch Drugs Limited or give up 0.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  Par Drugs And

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Kilitch Drugs Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Par Drugs And 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Par Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Kilitch Drugs and Par Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and Par Drugs

The main advantage of trading using opposite Kilitch Drugs and Par Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Par Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Par Drugs will offset losses from the drop in Par Drugs' long position.
The idea behind Kilitch Drugs Limited and Par Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format